Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ensysce Biosciences (ENSC) Treasury Shares (2022 - 2023)

Ensysce Biosciences (ENSC) has disclosed Treasury Shares for 2 consecutive years, with $63.0 as the latest value for Q3 2023.

  • On a quarterly basis, Treasury Shares fell 99.62% to $63.0 in Q3 2023 year-over-year; TTM through Sep 2023 was $63.0, a 99.62% decrease, with the full-year FY2022 number at $12000.0, changed N/A from a year prior.
  • Treasury Shares was $63.0 for Q3 2023 at Ensysce Biosciences, down from $377.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $16500.0 in Q3 2022 to a low of $63.0 in Q3 2023.